Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant?
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Aberrant activation of the innate immune systemin metabolic disorders such as type 2 diabeteshas been recognized to be an important mecha-nism of disease pathogenesis (1–3). Emergence of a chronic proinflammatory state driven by the activation of myeloid lineage innate immune cells, such as macro-phages and neutrophils, has been directly linked to the emergence of insulin resistance (4,5). Until recently, the identity of specific innate immune pattern recognition re-ceptors or sensors that recognize diverse metabolic “danger signals ” to initiate a proinflammatory cascade during obe-sity and diabetes was unknown. Pioneering studies from Tschopp and colleagues (6) identified that “inflamma-somes, ” the multiprotein cytosolic molecular platforms in myeloid cells, can sense damage-associated molecular pat-terns (DAMPs) and control the secretion of proinflam-matory cytokines interleukin (IL)-1b and IL-18 in metabolic stress. Structurally, inflammasomes consist of a Nod-like
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have demonstrated important roles of the NLRP3 inflammasome in aging and age-related diseases, such as atherosclerosis metabolic syndrome, type 2 diabetes, and Alzheimer’s disease (81–83).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737 · cited 2×
“This clinical trial reported increased b-cell secretory capacity but did not detect any changes in insulin resistance despite reduction in serum C-reactive protein (3).”
BackgroundCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080 · cited 1×
“The release of ATP from necrotic cells is also a potent trigger of inflammasome activation (14).”
BackgroundSelf-citationEndoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · cited 1×
“Metabolic distress, inflammation, and development of insulin-resistance are linked to increased oxidative stress emerging from mitochondria and unfolded protein response due to defective endoplasmic reticulum function (6,17).”
BackgroundThioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708 · cited 1×
“Consistent with studies in animal models (18), Lee et al.”
ResultThe NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Self-citationFatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698 · cited 2×
“Together with prior studies from Ting and colleagues (8), the current data from myeloid cells of type 2 diabetic patients corroborate the earlier findings that inhibition of AMP-activated protein kinase can exacerbate reactive oxygen species–dependent Nlrp3 inflammasome activation (11).”
BackgroundResultMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314 · cited 1×
“Emergence of a chronic proinflammatory state driven by the activation of myeloid lineage innate immune cells, such as macrophages and neutrophils, has been directly linked to the emergence of insulin resistance (4,5).”
BackgroundThe NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134 · cited 11×
“The knockdown of Nlrp3 and Asc via RNA interference in myeloid cells of type 2 diabetic patients prevented the ability of metabolic DAMPs to induce IL-1b and IL-18 secretion (11).”
BackgroundInfluentialNutrient sensing and inflammation in metabolic diseases
Hotamisligil, G. S., & Erbay, E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2449 · Cited by 1,040
Research works printed but not linked: 1
- XOMA 052 phase 2b top line results: Glucose control not demonstrated, positive anti-inflammatory effect, cardiovascular biomarker and lipid improvement and safety confirmed [press release online], 2011. Available from http://investors.xoma.com/releasedetail.cfm?ReleaseID=559470
Cited by
Ye, Y., Bajaj, M., Yang, H.-C., Perez-Polo, J. R., & Birnbaum, Y. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6725-2 · Cited by 368
McElwain, C. J., Tuboly, E., McCarthy, F. P., & McCarthy, C. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00655 · Cited by 208
SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway
Xu, H., Akinyemi, I. A., Chitre, S. A., Loeb, J. C., Lednicky, J. A., McIntosh, M. T., & Bhaduri-McIntosh, S. (2022) · Virology · doi:10.1016/j.virol.2022.01.003 · Cited by 176
“…such as diabetes, atherosclerosis, and obesity (all pro-inflammatory conditions marked by NLRP3 activation) (Chen et al., 2017; Dixit, 2013; Grant; Dixit, 2013; Jin and Fu, 2019; Rheinheimer et al., 2017; Stienstra et al., 2011) are at greater risk for severe disease (Richardson et al.,…”
Connecting aging biology and inflammation in the omics era
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158448 · Cited by 189
Corcoran, S. E., Halai, R., & Cooper, M. A. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000171 · Cited by 173
Inflammasomes link vascular disease with neuroinflammation and brain disorders
Lénárt, N., Brough, D., & Dénes, Á. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16662043 · Cited by 166
“NLRP1 is expressed in cortical neurons and CSF levels of ASC, caspase-1 and NLRP1 are increased in patients after traumatic brain injury.34,180 NLRP3 expression has also been found in the cerebral cortex after TBI in rats.182 Neutralisation of ASC or NLRP1 reduces inflammation and improves outcome in rats after trauma…”
BackgroundInfluentialStress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes
Novials, A., Montane, J., & Cadavez-Trigo, L. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s37649 · Cited by 159
NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
Góra, I. M., Ciechanowska, A., & Ładyżyński, P. (2021) · Cells · doi:10.3390/cells10020314 · Cited by 171
“The NLRP3 inflammasome also makes a significant contribution during the development of diabetes and its complications [11].”
BackgroundLahnwong, C., Chattipakorn, S. C., & Chattipakorn, N. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0745-5 · Cited by 161
Kim, S., & Lee, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.178 · Cited by 143
Sagoo, P., Garcia, Z., Bréart, B., Lemaître, F., Michonneau, D., Albert, M. L., Lévy, Y., & Bousso, P. (2015) · Nature Medicine · doi:10.1038/nm.4016 · Cited by 143
Rosales-Corral, S., Tan, D.-X., Manchester, L., & Reiter, R. J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/985845 · Cited by 128
“NLRP3 culminates in the activation of caspase-1 and releases IL-1β and IL-18, proinflammatory cytokines [58, 61, 62].”
BackgroundYin, Y., Zhou, Z., Liu, W., Chang, Q., Sun, G., & Dai, Y. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.01.001 · Cited by 137
Birnbaum, Y., Bajaj, M., Yang, H., & Ye, Y. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6778-x · Cited by 127
Han, W.-B., Ma, Q., Liu, Y., Wu, W., Tu, Y., Huang, L., Long, Y., Wang, W., Yee, H.-Y., Wan, Z.-Y., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.12.021 · Cited by 117
Wang, X., Zhai, Y., Xu, L., Qiao, C., Sun, X., Ding, J., Lu, M., & Hu, G. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.001 · Cited by 121
The intra‐ and extracellular functions of ASC specks
Franklin, B. S., Latz, E., & Schmidt, F. I. (2017) · Immunological Reviews · doi:10.1111/imr.12611 · Cited by 125
Inflammasomes and type 2 diabetes: An updated systematic review
Sepehri, Z., Kiani, Z., Afshari, M., Kohan, F., Dalvand, A., & Ghavami, S. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.10.010 · Cited by 107
Xu, Z., Qi, X., Bao, M., Zhou, T., Shi, J., Xu, Z., Zhou, M., Boccaccini, A. R., Zheng, K., & Jiang, X. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.01.024 · Cited by 91
Roshanravan, N., Alamdari, N. M., Jafarabadi, M. A., Mohammadi, A., Shabestari, B. R., Nasirzadeh, N., Asghari, S., Mansoori, B., Akbarzadeh, M., Ghavami, A., et al. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155101 · Cited by 94
Bakhshi, S., & Shamsi, S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108595 · Cited by 96
Yang, S., Xia, C., Li, S., Du, L., Zhang, L., & Zhou, R. (2014) · Redox Biology · doi:10.1016/j.redox.2014.04.001 · Cited by 91
Inflammasomes: Pandora’s box for sepsis
Kumar, V. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s178084 · Cited by 103
Birnbaum, Y., Bajaj, M., Qian, J., & Ye, Y. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000227 · Cited by 84
“23 25 26 It is reported that glyburide (sulfonylurea) prevents activation of in fl ammasome and delays lipopolysaccharide-induced lethality in mice.”
BackgroundInflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease
Mishra, A., & Brinton, R. D. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00312 · Cited by 79
“NLRP3 is also activated by the accumulation of damaged mitochondria due to the inhibition of autophagy, resulting in excessive production of ROS. oxidized mitochondrial DNA is also implicated in the activation of NLRP3 (Dixit, 2013).”
BackgroundBirnbaum, Y., Tran, D., Bajaj, M., & Ye, Y. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0743-0 · Cited by 72
Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?
Prattichizzo, F., Giuliani, A., Nigris, V. D., Pujadas, G., Çeka, A., Sala, L. L., Genovese, S., Testa, R., Procopio, A. D., Olivieri, F., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12688 · Cited by 72
“The NOD-like receptor (NLR)-caspase 1-IL-1β cascade can be activated by endogenous metabolism or injury-derived byproducts called damage-associated pattern molecules, resulting in chronic secretion of inflammatory cytokines [34,35].”
BackgroundA promiscuous inflammasome sparks replication of a common tumor virus
Burton, E. M., Goldbach‐Mansky, R. T., & Bhaduri‐McIntosh, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919133117 · Cited by 62
Lalitha, N., Bettadahalli, S., Ramaprasad, T. R., & Singh, S. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231543 · Cited by 60
“Activation of caspase-1 controls the cleavage and secretion of proIL-1β into bioactive cytokine [4].”
BackgroundPotential Role of Vitamin B6 in Ameliorating the Severity of COVID-19 and Its Complications
Kumrungsee, T., Zhang, P., Chartkul, M., Yanaka, N., & Katô, N. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.562051 · Cited by 62
Yang, L., Zhang, X., & Wang, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.992937 · Cited by 61
Therapeutic potential of multifunctional myricetin for treatment of type 2 diabetes mellitus
Niisato, N., & Marunaka, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1175660 · Cited by 62
Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases
Özenver, N., & Efferth, T. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105710 · Cited by 54
Dousdampanis, P., Aggeletopoulou, I., & Mouzaki, Α. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1534823 · Cited by 54
Qu, X., Zhai, B., Liu, Y., Chen, Y., Xie, Z., Wang, Q., Wu, Y., Liu, Z., Chen, J., Mei, S., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112998 · Cited by 54
Maes, M. H. J., Tedesco, W. L. D., Lozovoy, M. A. B., Mori, M. T. E., Danelli, T., de Almeida, E. R. D., Tejo, A. M., Tano, Z. N., Reiche, E. M. V., & Simão, A. N. C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01431-4 · Cited by 54
Sun, C., Fan, S., Wang, X., Lu, J., Zhang, Z., Wu, D., Shan, Q., & Zheng, Y. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.04.012 · Cited by 43
Sur, D., & Banu, S. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220630093359 · Cited by 41
Zhang, X., Liu, Y., Deng, G., Huang, B., Kai, G., Chen, K., & Li, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.676297 · Cited by 37
“The aberrant activation of the NLRP3 inflammasome is related to various diseases, including arthritis, cardiovascular disease, diabetes, and other rare genetic disorders (Dixit, 2013; Rowczenio et al., 2017; Yang et al., 2018; Zhou et al., 2018).”
BackgroundLee, J., Wan, J., Lee, L., Peng, C., Xie, H., & Lee, C. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0595-2 · Cited by 33
Zhang, H., Chen, H., Wu, X., Sun, T., Fan, M., Tong, H., Zhu, Y., Yin, Z., Sun, W., Zhang, C., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153860 · Cited by 33
L-ergothioneine reduces mitochondrial-driven NLRP3 activation in gestational diabetes mellitus
McElwain, C. J., Musumeci, A. G., Manna, S., McCarthy, F. P., & McCarthy, C. (2023) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2023.104171 · Cited by 33
Vaziri, Z., Saleki, K., Aram, C., Alijanizadeh, P., Pourahmad, R., Azadmehr, A., & Ziaei, N. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115686 · Cited by 31
Yao, R., Cao, Y., Wang, C., Xu, L. L., Zhang, X., Deng, Y., Li, F., & Wang, S. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03218-0 · Cited by 29
Ringling, R. E., Gastecki, M. L., Woodford, M. L., Lum‐Naihe, K., Grant, R. W., Pulakat, L., Vieira‐Potter, V. J., & Padilla, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161939 · Cited by 30
Ouyang, G., Wang, N., Tong, J., Sun, W., Yang, J., & Wu, G. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28400 · Cited by 29
“In the development of diabetes and its complications, the NLRP3 inflammasome plays an important role [54].”
BackgroundInhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice
Yang, L., Zhou, L., Wang, X., Wang, W., & Wang, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106987 · Cited by 29
Banerjee, A., & Singh, J. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10150 · Cited by 26
Cavalcante, J. E. A., de Sousa, E. L. H., Rodrigues, R. D. O., Viana, G. D. A., Gadelha, D. D., de Carvalho, M. M. D., de Sousa, D. L., Silva, A. J. X., Filho, R. R. B. X., Fernandes, V. O., et al. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.03.011 · Cited by 20
Leptin-depended NLRP3 inflammasome activation in osteoarthritic chondrocytes is mediated by ROS
Mourmoura, E., Papathanasiou, I. V., Trachana, V., Konteles, V., Tsoumpou, A., Goutas, A., Papageorgiou, A.-A., Stefanou, N., & Tsezou, A. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111730 · Cited by 22
Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
Hong, J., Fu, T., Liu, W., Du, Y., Bu, J., Wei, G., Yu, M., Lin, Y., Min, C., & Lin, D. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s441457 · Cited by 20
Bettcher, B. M., de Oliveira, F. F., Willette, A. A., Michalowska, M. M., Machado, L. S., Rajbanshi, B., Borelli, W. V., Tansey, M. G., da Rocha, A. S., Suryadevara, V., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03432-4 · Cited by 19
“For example, activity of the NLR family pyrin domain containing 3 (NLRP3) inflammasome in the periphery has been tied systemically to type 2 diabetes and in the brain to tau accumulation that often pre-cedes AD [65, 66].”
Ciobârcă, D., Cătoi, A. F., Gavrilaș, L., Banc, R., Miere, D., & Filip, L. A. (2025) · Pharmaceuticals · doi:10.3390/ph18020279 · Cited by 18
Zaher, A., & Stephens, S. B. (2025) · Cells · doi:10.3390/cells14060399 · Cited by 14
“In T2D, chronic low-grade inflammation sustained by NLRP3 activation exacerbates insulin resistance in peripheral tissues and decreases β -cell mass via IL-1 β -mediated apoptosis and pyroptosis [104].”
Interaction among inflammasome, autophagy and non-coding RNAs: new horizons for drug
Pu, Q., Lin, P., Wang, Z., Gao, P., Qin, S., Cui, L., & Wu, M. (2019) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbz019 · Cited by 10
Hiramatsu, T., Ito, H., Okumura, S., Asano, Y., Iguchi, D., & Furuta, S. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120971220 · Cited by 13
Li, F., & Ming, J. (2024) · Food & Function · doi:10.1039/d4fo01291g · Cited by 12
NLRP3-Inflammasome Gene Variations in the Risk of Type 2 Diabetes
Özbayer, C., Kurt, H., Yağcı, E., Kebapçı, M. N., Güneş, H. V., & Değirmenci, İ. (2021) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2021040001 · Cited by 13
Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Giannopoulos, C., Tzima, I. G., Tentolouris, N., & Vasileiadis, I. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230216112032 · Cited by 14
Prossomariti, A., Sokol, H., & Ricciardiello, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01039 · Cited by 13
Singh, N., Sharma, P., Pal, M. K., Kahera, R., Badoni, H., Pant, K., Sharma, N., & Bhist, B. (2025) · Scientific Reports · doi:10.1038/s41598-024-79054-2 · Cited by 11
“MCC950 functions by specifically blocking NLRP3 activation, which in turn decreases the production of key pro-inflammatory cytokines such as IL-1β and IL-18.”
Role of inflammasomes in diabetes mellitus: mechanisms, complications, and therapeutic potential
Milan, K. L., Megha, B., & Ramkumar, K. M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10719-5 · Cited by 12
Acierno, C., Frontuto, M., Stefano, G. F. D., Erezanu, A., Limone, A., Morella, S., Picaro, F., Palazzo, D., & Gilio, M. (2025) · Biomedicines · doi:10.3390/biomedicines13102513 · Cited by 11
“Such metabolic perturbations activate intracellular inflammatory pathways (JNK, NF-κ B) and amplify NLRP3 inflammasome activation, promoting a dysfunctional, pro-senescent immune response [42,43].”
Jang, A., Lee, H., Hong, J. J., Kim, Y.-M., & Park, J. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11827 · Cited by 10
Kuo, H., Chang, L., Chen, T., Lee, K., Lee, K.-F., Chen, C., & Yu, H. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00195 · Cited by 10
Guo, X., Wang, C., Zhang, R., Hao, X., Lv, L., Ni, Y., Fan, X., Zhang, W., Jiao, Y., Song, W., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.900021 · Cited by 10
“High glucose levels can activate the NLRP3 inflammatory body, which is linked to metabolic diseases like diabetes and obesity (Dixit, 2013; Wan et al., 2019; Rai et al., 2020).”
BackgroundNanoparticle-based delivery of polyphenols for the treatment of inflammation-associated diseases
Fuior, E.-V., & Călin, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819666-3.00012-2 · Cited by 10
Kewcharoenwong, C., Saenwongsa, W., Willcocks, S., Bancroft, G. J., Fletcher, H. A., & Lertmemongkolchai, G. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.101939 · Cited by 9
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo
Andreozzi, F., Fatta, C. D., Spiga, R., Mannino, G. C., Mancuso, E., Averta, C., Caro, C. D., Tallarico, M., Leo, A., Citraro, R., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14902 · Cited by 8
Exploring the Focal Role of Pyroptosis in Diabetes Mellitus
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac115.1355713572 · Cited by 5
“Overproduction of ROS, endoplasmic stress and ATP production is known as metabolic stress for the body [77].”
BackgroundBehshad, S., Mohammadi, Y., Sarab, G. A., Malekaneh, M., & Farimani, A. R. (2025) · Health Science Reports · doi:10.1002/hsr2.70770 · Cited by 4
“One type of the NLR molecule is a NLRP3 [6].”
Regulation and therapeutic potential of NLRP3 inflammasome in intestinal diseases
Li, W., Liu, T., Chen, Y., Sun, Y., Li, C., & Dong, Y. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf014 · Cited by 4
Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy
Zhang, Q., Yang, M., Xiao, Y., Han, Y., Yang, S., & Sun, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191108160643 · Cited by 5
Molecular mechanisms in the pathogenesis of metabolically associated fatty liver disease
Durkovicova, Z., Faktorová, X., Jakabovičová, M., & Szántová, M. (2023) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2023_065 · Cited by 4
Regulation of NLRP3 activation by the ubiquitin system
López‐Castejón, G. (2013) · Inflammasome · doi:10.2478/infl-2013-0003 · Cited by 3
Effects of Genistein on Inflammasome Induced Pancreatic β‐Cell Apoptosis by Dexamethasone
Jitprawet, N., Sujjitjoon, J., Maneethorn, P., Semprasert, N., & Kooptiwut, S. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70218 · Cited by 1
“Dixit et al. (2013) has been reported that NLRP3 recruits an adaptor protein, ASC, and assembles it as an NLRP3 inflammasome [40].”
Leucine and Resveratrol: Experimental Model of Sirtuin Pathway Activation
Bruckbauer, A., & Zemel, M. B. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1923-9_8 · Cited by 1
The role of tyrosine phosphorylation in inflammasome complex formation and function.
Mambwe, B. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Sancho, M., Soriano‐Teruel, P. M., & Orzáez, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00038-4
Επιγενετικοί μηχανισμοί στην εκφυλιστική νόσο των αρθρώσεων
Papageorgiou, A.-A. (2024) · doi:10.12681/eadd/56263
Ma, S., Cui, M., Chang, K., Yang, G., Li, L., Kou, B., Xu, B., Li, Y., Liu, F., Jin, M., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102994
“In addition, chronic low-grade inflammation destabilizes the bone – implant interface [7].”
Liss, C. M., Elmarakby, A. A., Sullivan, K., Hanson, P. R., Belanger, K., Mohamed, R., Mattson, D. L., Taylor, E. B., Ryan, M. J., & Sullivan, J. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.17.712521
Juruj, C. (2013) · theses.fr (ABES) · doi:10.70675/8f8f5168z111az4a9bzb0d4z0ed113ba0f1a
Grudniewska, A., Mrozikiewicz‐Rakowska, B., Wiszniewski, K., Bik, W., Szabłowska‐Gadomska, I., & Kuryłowicz, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209055
“Saturated free fatty acids (FFAs), ceramides, extracellular ATP, mitochondrial DNA (mtDNA), cholesterol crystals, lysosomal cathepsins and reactive oxygen species (ROS) originate from distinct cellular compartments and arise through different pathogenic mechanisms [6,7,25,26,32,33].”
InfluentialGrudniewska, A., Mrozikiewicz‐Rakowska, B., Wiszniewski, K., Dudek, P., & Kuryłowicz, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209356
“Pre-clinical studies reported reduced expression of genes involved in the differentiation of haematopoietic progenitors toward NKT cells and γδ T lymphocytes in the setting of hypercholesterolaemia, suggesting a broader effect of systemic lipid excess on antitumour immune competence [66,67].”
Trigo, L. D. G. C. (2014) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Metadata
- Authors
- Dixit, V. D.
- Affiliations
- Pennington Biomedical Research Center (US)
- Corresponding author
- Dixit, Vishwa Deep
- ORCID
- Dixit, Vishwa Deep
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-12-13
- Volume
- 62
- Issue
- 1
- Pages
- 22-24
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3526045
- OpenAlex
- W2130502531
- Cited by
- 85
- References
- 22
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 2 · 2023: 8 · 2022: 11 · 2021: 8 · 2020: 11 · 2019: 4 · 2018: 7 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 4
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG031797)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK090556, P30DK072476)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, type 2 diabetes, innate immunity, insulin resistance, inflammation, myeloid cells, macrophages, neutrophils, damage-associated molecular patterns, IL-1β, IL-18, obesity, metabolic stress
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Carrier Proteins, Diabetes Mellitus, Type 2, Female, Humans, Male, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.